1. How to bring accessible
technologies to clinic ?
Bala Sirigireddy
FIBMS
Clinical entrepreneur fellow- NHSE
CENT fellow – Royal Society of Medicine
2. Sometimes it is all about being in
the right place at right time
Are we in the right place ? is it the right time for digital disruption in health care ?
3. I believe so….
These are the factors contributing to the belief
Affordable cloud technologies – Azure and
Amazon
Easily customisable off the shelf Artificial
intelligence and Machine Learning
Interoperability with EPR ( FIHR standards,
HL7 v.4)
Proliferation of wearables and health apps
Global hype – Increase in Venture Capitalists
investing in health tech start-ups
Last but not least a tech friendly health
secretary Matt Hancock
4. We publish research work frequently and
thought of applying theses technologies
to innovate
5. ?
Problem
Lack of real time
data capture
mechanism to
innovatively
manage chronic
conditions
Market
Aging population
and increase in
patients with
chronic conditions
poses significant
challenges to
health economics
Solution
Wearable
technology
combined with
Machine learning
and AI to enable
better decisions
Mission
Organise data
from sensors for
the discovery of
digital biomarkers
6. ?
Problem
Lack of real
time data
capture
platform in
sickle cell
Market15000 pts in UK,
Cost to NHS =
240 MN /year,
150K patients in US and
4 million worldwide
Solution
Wearable
technology which
can capture vital
signs like Pulse
oxygen, HRV,
temperature, sleep
Mission
Organise data from
sensors for the
discovery of digital
biomarkers which
can help to predict
deterioration and
provide behavioural
nudges
However, we did not have a full tech spec before going into program
We took the idea to NHSE and got into Clinical entrepreneur program
7. Things learned at Clinical entrepreneur program
Writing a Business plan - revenue models
Building a team
Funding sources - NIHR, Innovate UK, SBRI.
Pitching your ideas to investors -Seed, Angel and
VC’s
Digital Marketing and branding
Minimum Viable Product (MVP) developed through
knowledge gained from networking
(Hard to get funding with out MVP & Pilot site)
9. Understanding quality
Data for business intelligence
Understanding efficiency
Improving safety
Real-time comparisons
Better planning
Compliance with national plans for digital transformation
Slide Source: Dr Simon Eccles
10. Going forward
Complete the pilot in stages, R&D
and ethics approval application in
progress.
Discover digital biomarkers for
Sickle cell patients
Apply for patents where applicable
Get investors on-board
Scale nationally and globally
Thank you
Editor's Notes
1) No real mechanism to capture data from patient in real time, most data is episodic, not quantified self
2) Proliferation of technologies like wearable, cloud, AI and ML does the the heavy lifting and can provide actionable data which could be used to improve outcomes
BIG data, IOT, CLOUD, Analytics
3) Aging population and increase in patients with chronic conditions poses significant challenges to health economics
4) Organise data from sensors for the discovery of digital biomarkers, to enable early detection of deteriorations, digital diagnostics and track progress.
1) No real mechanism to capture data from patient in real time, most data is episodic, not quantified self
2) Proliferation of technologies like wearable, cloud, AI and ML does the the heavy lifting and can provide actionable data which could be used to improve outcomes
BIG data, IOT, CLOUD, Analytics
3) Aging population and increase in patients with chronic conditions poses significant challenges to health economics
4) Organise data from sensors for the discovery of digital biomarkers, to enable early detection of deteriorations, digital diagnostics and track progress.
we developed minimum viable product (MVP) by leveraging networks from CENT program and personal contacts
Data Flow:
Fitbit sensors for Sleep, Pulse oxygen, HRV----Fitbit app----AWS repository ---- Kibana Dashboard-----AWS conversion for HL7------Cerner EPR
We need to ensure that data is available at the time and place it is needed so we have the business intelligence we need to make the best decisions for patients